Versigent (NYSE:VGNT - Get Free Report) had its price target increased by equities researchers at Argus from $50.00 to $54.00 in a report released on Thursday,Benzinga reports. The firm presently has a "buy" rating on the stock. Argus' price objective points to a potential upside of 18.66% from the company's previous close.
A number of other analysts have also commented on the company. TD Cowen lifted their price target on Versigent from $49.00 to $58.00 and gave the stock a "buy" rating in a report on Wednesday, August 5th. Fox Advisors downgraded Versigent from an "overweight" rating to an "equal weight" rating in a research note on Wednesday, August 5th. Wolfe Research began coverage on Versigent in a research report on Thursday, April 30th. They set an "outperform" rating and a $53.00 target price for the company. Wells Fargo & Company raised their target price on Versigent from $48.00 to $56.00 and gave the company an "overweight" rating in a research report on Wednesday, August 5th. Finally, Weiss Ratings began coverage on Versigent in a research note on Wednesday, August 5th. They set a "hold (c)" rating on the stock. Eleven analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $54.00.
View Our Latest Research Report on Versigent
Versigent Stock Performance
Shares of Versigent stock opened at $45.51 on Thursday. The firm has a market capitalization of $3.22 billion and a PE ratio of 23.70. Versigent has a 52 week low of $26.34 and a 52 week high of $50.88. The firm has a 50 day moving average price of $43.28. The company has a quick ratio of 1.09, a current ratio of 1.40 and a debt-to-equity ratio of 7.29.
Versigent (NYSE:VGNT - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $1.92 EPS for the quarter, topping analysts' consensus estimates of $1.58 by $0.34. The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.29 billion. Research analysts forecast that Versigent will post 7.22 EPS for the current year.
Versigent Company Profile
(
Get Free Report)
Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Versigent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Versigent wasn't on the list.
While Versigent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.